NovoCure Ltd
NVCR
Market Cap$1.3B
Close$
$1.96
84.1% downside
Current Fair Value
84.1% downsideOvervalued by 84.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.30 Billion |
|---|---|
| Enterprise Value | $954.86 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.95 |
| Beta | 1.62 |
| Outstanding Shares | 107,606,309 |
| Avg 30 Day Volume | 1,818,430 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.26 |
|---|---|
| PEG | -23.9 |
| Price to Sales | 3.09 |
| Price to Book Ratio | 4.11 |
| Enterprise Value to Revenue | 1.87 |
| Enterprise Value to EBIT | -4.1 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.6 |
| Debt to Equity | 1.57 |
Revenue Sources
No data
ESG Score
No data
About NovoCure Ltd
CEO: Asaf Danziger